Tekla Capital Management as of June 30, 2013
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 60 positions in its portfolio as reported in the June 2013 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 10.5 | $77M | 1.5M | 51.21 | |
| Regeneron Pharmaceuticals (REGN) | 8.6 | $63M | 280k | 224.88 | |
| Celgene Corporation | 8.1 | $60M | 510k | 116.91 | |
| Biogen Idec (BIIB) | 5.6 | $41M | 192k | 215.20 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.9 | $36M | 454k | 79.87 | |
| Alexion Pharmaceuticals | 4.7 | $34M | 371k | 92.24 | |
| Puma Biotechnology (PBYI) | 4.3 | $32M | 712k | 44.37 | |
| Perrigo Company | 3.3 | $25M | 203k | 121.00 | |
| Onyx Pharmaceuticals | 3.0 | $22M | 254k | 86.82 | |
| Amgen (AMGN) | 2.7 | $20M | 200k | 98.66 | |
| Warner Chilcott Plc - | 2.1 | $16M | 783k | 19.88 | |
| Mylan | 2.1 | $15M | 488k | 31.03 | |
| Shire | 2.0 | $15M | 154k | 95.11 | |
| Merck & Co (MRK) | 1.9 | $14M | 297k | 46.45 | |
| Cubist Pharmaceuticals | 1.8 | $13M | 266k | 48.30 | |
| Akorn | 1.7 | $13M | 936k | 13.52 | |
| Aetna | 1.7 | $13M | 197k | 63.54 | |
| Verastem | 1.7 | $12M | 885k | 13.88 | |
| Teva Pharmaceutical Industries (TEVA) | 1.7 | $12M | 312k | 39.20 | |
| Actavis | 1.6 | $12M | 92k | 126.22 | |
| Hologic (HOLX) | 1.6 | $11M | 593k | 19.30 | |
| Medivation | 1.4 | $10M | 206k | 49.20 | |
| Neurocrine Biosciences (NBIX) | 1.3 | $9.5M | 708k | 13.38 | |
| Incyte Corporation (INCY) | 1.3 | $9.3M | 421k | 22.00 | |
| Questcor Pharmaceuticals | 1.1 | $7.9M | 174k | 45.46 | |
| Allergan | 1.1 | $7.8M | 93k | 84.24 | |
| Amarin Corporation (AMRN) | 1.1 | $7.9M | 1.4M | 5.80 | |
| Illumina (ILMN) | 1.1 | $7.8M | 104k | 74.84 | |
| Alere | 1.1 | $7.8M | 317k | 24.50 | |
| Ironwood Pharmaceuticals (IRWD) | 1.0 | $7.6M | 768k | 9.95 | |
| Ariad Pharmaceuticals | 1.0 | $7.2M | 413k | 17.49 | |
| Impax Laboratories | 0.9 | $6.9M | 345k | 19.95 | |
| McKesson Corporation (MCK) | 0.9 | $6.5M | 57k | 114.51 | |
| ImmunoGen | 0.9 | $6.5M | 394k | 16.59 | |
| Forest Laboratories | 0.8 | $6.0M | 147k | 41.00 | |
| Sagent Pharmaceuticals | 0.8 | $5.7M | 270k | 20.98 | |
| Alkermes (ALKS) | 0.8 | $5.6M | 195k | 28.68 | |
| Baxter International (BAX) | 0.7 | $5.4M | 78k | 69.28 | |
| UnitedHealth (UNH) | 0.7 | $5.4M | 82k | 65.48 | |
| IDEXX Laboratories (IDXX) | 0.7 | $5.1M | 56k | 89.77 | |
| Endo Pharmaceuticals | 0.6 | $4.6M | 126k | 36.79 | |
| BioMarin Pharmaceutical (BMRN) | 0.6 | $4.2M | 75k | 55.79 | |
| Accuray Incorporated (ARAY) | 0.6 | $4.2M | 732k | 5.74 | |
| CVS Caremark Corporation (CVS) | 0.6 | $4.1M | 72k | 57.19 | |
| Acorda Therapeutics | 0.5 | $3.7M | 113k | 32.99 | |
| Merrimack Pharmaceuticals In | 0.5 | $3.6M | 538k | 6.73 | |
| Elan Corporation | 0.5 | $3.4M | 243k | 14.14 | |
| Rigel Pharmaceuticals | 0.4 | $2.8M | 827k | 3.34 | |
| Intellipharmaceuticsintl Inc C | 0.4 | $2.8M | 1.7M | 1.62 | |
| Auxilium Pharmaceuticals | 0.3 | $2.1M | 128k | 16.63 | |
| Synta Pharmaceuticals | 0.3 | $1.9M | 377k | 4.99 | |
| Dendreon Corporation | 0.2 | $1.6M | 377k | 4.12 | |
| Ceres | 0.2 | $1.3M | 417k | 3.13 | |
| OncoGenex Pharmaceuticals | 0.1 | $1.1M | 113k | 9.80 | |
| Mei Pharma | 0.1 | $1.1M | 149k | 7.13 | |
| Supernus Pharmaceuticals (SUPN) | 0.1 | $905k | 141k | 6.43 | |
| Endocyte | 0.1 | $790k | 60k | 13.12 | |
| Cornerstone Therapeutics | 0.1 | $529k | 66k | 8.00 | |
| Icad (ICAD) | 0.1 | $531k | 89k | 6.00 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $200k | 104k | 1.93 |
